Histatin-5 vs Mazdutide
Head-to-head comparison of Histatin-5 (Human histatin 5) and Mazdutide (IBI362, long-acting GLP-1 receptor and glucagon receptor dual agonist) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Histatin-5 | Mazdutide |
|---|---|---|
| Category | Dental & Oral | Weight Management |
| Full Name | Human histatin 5 | IBI362, long-acting GLP-1 receptor and glucagon receptor dual agonist |
| Molecular Weight | 3035 Da | ~5,000 Da |
| Half-Life | minutes in saliva | 5-7 days |
| Amino Acids | 24 | 37 |
| Typical Dose | 1-100 µM in research formulations | 1-6 mg weekly in obesity trials |
| Route | Topical/Oral rinse | Subcutaneous |
| Purity | ≥98% | ≥98% |
| Studies Count | 120 | 28 |
| Research Status | Pre-clinical | Clinical |
Histatin-5 Benefits
- ✓anti-Candida activity
- ✓biofilm suppression
- ✓mucosal wound support
- ✓oral innate immunity
Mazdutide Benefits
- ✓clinically meaningful weight loss
- ✓better glycemic control
- ✓reduced waist circumference
- ✓improved lipid profile
Histatin-5 Dosing
topical rinse or gel|short contact exposure|repeat applications in research protocols
Mazdutide Dosing
Once-weekly SC titration|Dose escalation every 4 weeks|Use with lifestyle modification
Histatin-5 Side Effects
- ⚠local irritation
- ⚠proteolytic instability
- ⚠dose-dependent cytotoxicity in vitro
Mazdutide Side Effects
- ⚠nausea
- ⚠vomiting
- ⚠constipation
Research Overview
Histatin-5
Histatin-5 is a major salivary defense peptide that can kill Candida species and influence oral microbial communities. It is also investigated for wound-healing and xerostomia-associated oral infection models.
Mazdutide
Clinical programs have shown substantial reductions in body weight and improvements in cardiometabolic risk markers. It is a prominent newer dual agonist in the obesity literature.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.